Farmington, United States
Intus Bio, established in 2015, is an innovative leader in the Biotechnology, Health Care, and Clean Energy sectors, headquartered in the United States. The company is pioneering advancements with its proprietary high-resolution, high-throughput assay and analysis technology, offering unmatched detail and accuracy in microbiome research.
Their technology is enhancing research and development across industries such as pharmaceuticals, diagnostics, and testing. Intus Bio is also making significant strides in health, agriculture, and environmental sectors, pushing the boundaries of discovery and collaboration with new partnerships.
The company continues its growth trajectory, as evidenced by a recent Debt Financing investment on 16 July 2024. With its focus on cutting-edge solutions and expansive industry engagement, Intus Bio presents an enticing opportunity for investors looking for impact within the microbiome and broader biotechnological landscape.
